We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Invest in Neuberger Berman Genesis Investor Fund (NBGNX)?
Read MoreHide Full Article
Neuberger Berman Genesis Investor Fund (NBGNX - Free Report) seeks growth of capital. The portfolio managers seek long-term capital growth by investing in companies that are still in their early stages of development. NBGNX invests primarily in common stocks of small-sized companies, generally below $1.5 billion in market capitalization at the time of initial investment. NBGNX believes the small-cap arena offers long-term investors big opportunities - unlike large-caps, small-cap companies start from a very low base and, therefore, may have the ability to grow earnings dramatically over time. The managers look for undervalued companies whose current product lines and balance sheets are strong.
This Small Cap Value product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 11% and 5 year 12.6%. To see how this fund performed compared in its category, and #1 and #2 Ranked Mutual Funds, please click here.
The Neuberger Berman Genesis Investor fund, as of the last filing, allocates their fund in top two major groups; Small Growth and Small Value. Further, as of the last filing, West Pharmaceutical Services Inc, Pool Corp and Sensient Technologies Corp were the top holdings for NBGNX.
This Zacks Rank #3 (Hold) was incepted in September 1988 and is managed by Neuberger. NBGNX carries an expense ratio of 1.03% and requires a minimal initial investment of $1,000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Invest in Neuberger Berman Genesis Investor Fund (NBGNX)?
Neuberger Berman Genesis Investor Fund (NBGNX - Free Report) seeks growth of capital. The portfolio managers seek long-term capital growth by investing in companies that are still in their early stages of development. NBGNX invests primarily in common stocks of small-sized companies, generally below $1.5 billion in market capitalization at the time of initial investment. NBGNX believes the small-cap arena offers long-term investors big opportunities - unlike large-caps, small-cap companies start from a very low base and, therefore, may have the ability to grow earnings dramatically over time. The managers look for undervalued companies whose current product lines and balance sheets are strong.
This Small Cap Value product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 11% and 5 year 12.6%. To see how this fund performed compared in its category, and #1 and #2 Ranked Mutual Funds, please click here.
The Neuberger Berman Genesis Investor fund, as of the last filing, allocates their fund in top two major groups; Small Growth and Small Value. Further, as of the last filing, West Pharmaceutical Services Inc, Pool Corp and Sensient Technologies Corp were the top holdings for NBGNX.
This Zacks Rank #3 (Hold) was incepted in September 1988 and is managed by Neuberger. NBGNX carries an expense ratio of 1.03% and requires a minimal initial investment of $1,000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>